Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Singleton

Showing results (181-190 of 286) with videos related to

Pageof 29
Sort By:
Neurobiology of Aging|June 2, 2014
Exome sequencing identifies 2 novel presenilin 1 mutations (p.L166V and p.S230R) in British early-onset Alzheimer's diseaseCeleste Sassi, Rita Guerreiro, Raphael Gibbs, et al.
The Journal of Clinical Endocrinology and Metabolism|May 22, 2008
A common variation in deiodinase 1 gene DIO1 is associated with the relative levels of free thyroxine and triiodothyronineVijay Panicker, Christie Cluett, Beverley Shields, et al.
Plos Medicine|June 14, 2017
Estimating the causal influence of body mass index on risk of Parkinson disease: A Mendelian randomisation studyAlastair J Noyce, Demis A Kia, Gibran Hemani, et al.
American Journal of Human Genetics|February 3, 2009
Common variation in the beta-carotene 15,15'-monooxygenase 1 gene affects circulating levels of carotenoids: a genome-wide association studyLuigi Ferrucci, John R B Perry, Amy Matteini, et al.
Medrxiv : the Preprint Server for Health Sciences|July 17, 2025
MEDICATION EXPOSURE AND NEURODEGENERATIVE DISEASE RISK ACROSS NATIONAL BIOBANKSKristin S Levine, Lana Sargent, Emma N Somerville, et al.
Archives of Neurology|May 11, 2011
SCA15 due to large ITPR1 deletions in a cohort of 333 white families with dominant ataxiaCecilia Marelli, Joyce van de Leemput, Janel O Johnson, et al.
JAMA Neurology|August 28, 2013
Association of cerebrospinal fluid β-amyloid 1-42, T-tau, P-tau181, and α-synuclein levels with clinical features of drug-naive patients with early Parkinson diseaseJu-Hee Kang, David J Irwin, Alice S Chen-Plotkin, et al.
Movement Disorders Clinical Practice|June 19, 2023
Impact of the Dopamine System on Long-Term Cognitive Impairment in Parkinson Disease: An Exploratory StudyDaniel Weintraub, Marina Picillo, Hyunkeun Ryan Cho, et al.
Archives of Neurology|January 12, 2005
A rare truncating mutation in ADH1C (G78Stop) shows significant association with Parkinson disease in a large international sampleSilvia Buervenich, Andrea Carmine, Dagmar Galter, et al.
Medrxiv : the Preprint Server for Health Sciences|October 7, 2024
Gut-Brain Nexus: Mapping Multi-Modal Links to Neurodegeneration at Biobank ScaleMohammad Shafieinouri, Samantha Hong, Artur Schuh, et al.
Pageof 29

Showing results (181-190 of 286) with videos related to

Sort By:
Pageof 29
Neurobiology of Aging|June 2, 2014
Exome sequencing identifies 2 novel presenilin 1 mutations (p.L166V and p.S230R) in British early-onset Alzheimer's diseaseCeleste Sassi, Rita Guerreiro, Raphael Gibbs, et al.
The Journal of Clinical Endocrinology and Metabolism|May 22, 2008
A common variation in deiodinase 1 gene DIO1 is associated with the relative levels of free thyroxine and triiodothyronineVijay Panicker, Christie Cluett, Beverley Shields, et al.
Plos Medicine|June 14, 2017
Estimating the causal influence of body mass index on risk of Parkinson disease: A Mendelian randomisation studyAlastair J Noyce, Demis A Kia, Gibran Hemani, et al.
American Journal of Human Genetics|February 3, 2009
Common variation in the beta-carotene 15,15'-monooxygenase 1 gene affects circulating levels of carotenoids: a genome-wide association studyLuigi Ferrucci, John R B Perry, Amy Matteini, et al.
Medrxiv : the Preprint Server for Health Sciences|July 17, 2025
MEDICATION EXPOSURE AND NEURODEGENERATIVE DISEASE RISK ACROSS NATIONAL BIOBANKSKristin S Levine, Lana Sargent, Emma N Somerville, et al.
Archives of Neurology|May 11, 2011
SCA15 due to large ITPR1 deletions in a cohort of 333 white families with dominant ataxiaCecilia Marelli, Joyce van de Leemput, Janel O Johnson, et al.
JAMA Neurology|August 28, 2013
Association of cerebrospinal fluid β-amyloid 1-42, T-tau, P-tau181, and α-synuclein levels with clinical features of drug-naive patients with early Parkinson diseaseJu-Hee Kang, David J Irwin, Alice S Chen-Plotkin, et al.
Movement Disorders Clinical Practice|June 19, 2023
Impact of the Dopamine System on Long-Term Cognitive Impairment in Parkinson Disease: An Exploratory StudyDaniel Weintraub, Marina Picillo, Hyunkeun Ryan Cho, et al.
Archives of Neurology|January 12, 2005
A rare truncating mutation in ADH1C (G78Stop) shows significant association with Parkinson disease in a large international sampleSilvia Buervenich, Andrea Carmine, Dagmar Galter, et al.
Medrxiv : the Preprint Server for Health Sciences|October 7, 2024
Gut-Brain Nexus: Mapping Multi-Modal Links to Neurodegeneration at Biobank ScaleMohammad Shafieinouri, Samantha Hong, Artur Schuh, et al.
Pageof 29